000 01492 a2200397 4500
005 20250517150135.0
264 0 _c20180301
008 201803s 0 0 eng d
022 _a1573-7209
024 7 _a10.1007/s10456-017-9549-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBani, MariaRosa
245 0 0 _aContribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonists.
_h[electronic resource]
260 _bAngiogenesis
_cMay 2017
300 _a233-241 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _a3T3 Cells
650 0 4 _aATP Binding Cassette Transporter, Subfamily B
_xantagonists & inhibitors
650 0 4 _aAngiogenesis Inhibitors
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aDoxorubicin
_xpharmacology
650 0 4 _aDrug Resistance, Neoplasm
_xdrug effects
650 0 4 _aHuman Umbilical Vein Endothelial Cells
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aNeoplasm Proteins
_xantagonists & inhibitors
650 0 4 _aNeoplasms
_xblood supply
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aDecio, Alessandra
700 1 _aGiavazzi, Raffaella
700 1 _aGhilardi, Carmen
773 0 _tAngiogenesis
_gvol. 20
_gno. 2
_gp. 233-241
856 4 0 _uhttps://doi.org/10.1007/s10456-017-9549-6
_zAvailable from publisher's website
999 _c27061726
_d27061726